Home | Contact Us | Site Map

Ganaxolone About Ganaxolone Ganaxolone for Partial Complex Seizures Ganaxolone for PTSD Ganaxolone for Fragile-X Syndrome References & Scientific Support

Marinus is dedicated to bringing ganaxolone therapies to market to treat a number of severe central nervous system (CNS) disorders. In addition to ganaxolone trials in adult partial seizures, the company has ongoing and planned clinical trials in the treatment of posttraumatic stress disorder and fragile-X syndrome.

© Marinus Pharmaceuticals